Fractyl Health

company

About

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

  • 51 - 100

Details

Last Funding Type
Series F
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2010
Number Of Employee
51 - 100
Operating Status
Active

Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.

Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$120.76M
Fractyl Health has raised a total of $120.76M in funding over 2 rounds. Their latest funding was raised on Aug 15, 2022 from a Series F round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 15, 2022 Series F 1 Detail
Nov 30, 2017 Series D $44M 2 Detail
Nov 19, 2015 Series C $57M 1 Detail
Sep 4, 2014 Series B $19.76M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Fractyl Health is funded by 2 investors. General Catalyst and iDo Fund are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Series F
iDo Fund Series D